Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R.D.K. Reye, G. Morgan, J. Basal.
Encephalopaty and fatty degeneration of the viscera. A disease entity in childhood.
Lancet, 2 (1963), pp. 749-752
[2.]
W.F. Balisteri.
Síndrome de Reye y enfermedades "tipo Reye".
Nelson. Tratado de Pediatría, pp. 1330-1332
[3.]
J.P. Orlowski.
Whatever happened to Reye's syndrome? Did it ever really exist?.
Crit Care Med, 27 (1999), pp. 1582-1587
[4.]
M. Casteels-Van Daele, C.H. Van Geet, C. Wouters, E. Eggermont.
Reye Syndome revisted: a descriptive term covering a group of heterogeneous disorders.
Eur J Pediatr, 159 (2000), pp. 641-648
[5.]
J.M. Saudubray, C.H. Charpentier.
Clinical phenotypes: diagnosis/ algorithms.
The metabolic and molecular bases of inherited disease, pp. 1327-1403
[6.]
J.F.T. Glasgow, B. Middelton.
Rye Syndrome-insights on causation and prognosis.
Arch Dis Child, 85 (2001), pp. 351-353
[7.]
J.B. Arrowsmith, D.L. Kennedy, J.N. Kuritsky, G.A. Faich.
National patterns of aspirin use and Reye syndrome reporting, United States, 1980 to 1985.
Pediatrics, 79 (1987), pp. 858-863
[8.]
K.M. Starjo, C.G. Ray, L.B. Domínguez.
Reye's syndrome and salicilate use.
Pediatrics, 66 (1980), pp. 859-864
[9.]
A.S. Monto.
The disappearance of Reye's syndrome- a public health triumph.
N Eng J Med, 340 (1999), pp. 1423-1424
[11.]
S.M. Hall, P.A. Plaster, J.F.T. Glasgow, P. Hancok.
Pre-admission antipyretics in Reye's syndrome.
Arch Dis Child, 63 (1988), pp. 857-866
[12.]
J.M. Quintilla, J. Campistol, M.D. Boleda, M.A. Vilaseca, R. Artuch, A. Palomeque, et al.
Síndrome de Reye como manifestación inicial de enfermedad mitocondrial.
An Esp Pediatr, 52 (2000), pp. 479-482
[13.]
J.F. Glasgow, B. Middelton, R. Moore, A. Gray, J. Hill.
The mechanims of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye syndrome patients and controls.
Biocchim Biophys Acta, 1454 (1999), pp. 115-125
Copyright © 2003. Asociación Española de Pediatría
